title: MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: yes.
authors.affiliation: Biostatistics Unit, Department of Health Sciences, University of Genoa, Italy.
authors.forename: Maria Pia
authors.initials: MP
authors.lastname: Sormani
authors.forename: Nicola
authors.initials: N
authors.lastname: De Stefano
mesh_terms: D006801:Humans; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000473:pathology*; D017063:Outcome Assessment, Health Care; D016032:Randomized Controlled Trials as Topic; D012107:Research Design